DENTSPLY SIRONA Inc (NASDAQ:XRAY) Position Trimmed by MetLife Investment Advisors LLC

MetLife Investment Advisors LLC lessened its holdings in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 1.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 63,638 shares of the medical instruments supplier’s stock after selling 1,037 shares during the period. MetLife Investment Advisors LLC’s holdings in DENTSPLY SIRONA were worth $2,368,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the company. Private Capital Group LLC boosted its stake in shares of DENTSPLY SIRONA by 105.3% during the 4th quarter. Private Capital Group LLC now owns 700 shares of the medical instruments supplier’s stock worth $26,000 after acquiring an additional 359 shares during the period. Harel Insurance Investments & Financial Services Ltd. acquired a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $26,000. Truehand Inc acquired a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $27,000. Enlightenment Research LLC acquired a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $30,000. Finally, Claybrook Capital LLC acquired a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $38,000. Institutional investors own 96.30% of the company’s stock.

Several brokerages have weighed in on XRAY. HC Wainwright set a $49.00 price objective on DENTSPLY SIRONA and gave the company a “hold” rating in a report on Friday, April 5th. BidaskClub raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Tuesday, April 16th. Robert W. Baird boosted their price target on DENTSPLY SIRONA from $42.00 to $50.00 and gave the stock a “neutral” rating in a report on Monday, March 4th. UBS Group boosted their price target on DENTSPLY SIRONA from $42.00 to $53.00 and gave the stock a “neutral” rating in a report on Tuesday, March 12th. Finally, Barclays set a $49.00 price objective on DENTSPLY SIRONA and gave the stock a “hold” rating in a research report on Friday, March 1st. One analyst has rated the stock with a sell rating, nine have given a hold rating and eight have given a buy rating to the company. DENTSPLY SIRONA has a consensus rating of “Hold” and an average target price of $52.25.

XRAY stock traded up $0.97 during trading on Friday, reaching $49.73. 2,172,091 shares of the stock were exchanged, compared to its average volume of 1,302,021. DENTSPLY SIRONA Inc has a twelve month low of $33.93 and a twelve month high of $51.50. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.27 and a current ratio of 1.86. The company has a market cap of $11.13 billion, a P/E ratio of 24.74, a price-to-earnings-growth ratio of 2.23 and a beta of 1.11.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Friday, March 1st. The medical instruments supplier reported $0.58 EPS for the quarter, topping the consensus estimate of $0.54 by $0.04. The firm had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.02 billion. DENTSPLY SIRONA had a positive return on equity of 8.21% and a negative net margin of 25.36%. The company’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.82 earnings per share. Equities analysts predict that DENTSPLY SIRONA Inc will post 2.31 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were issued a dividend of $0.087 per share. This represents a $0.35 annualized dividend and a yield of 0.70%. The ex-dividend date of this dividend was Thursday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is 17.41%.

TRADEMARK VIOLATION WARNING: This story was posted by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://www.baseballdailydigest.com/news/2019/04/21/metlife-investment-advisors-llc-decreases-holdings-in-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Recommended Story: Why is the price-sales ratio important?

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.